Evidence map›Paper›PMID 28991239›Full record

ArticleNature chemical biology2017

Stendomycin selectively inhibits TIM23-dependent mitochondrial protein import.

Ireos Filipuzzi, Janos Steffen, Mitchel Germain, Laetitia Goepfert, Michael A Conti, Christoph Potting, Raffaele Cerino, Martin Pfeifer, Philipp Krastel, Dominic Hoepfner and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Ireos FilipuzziNovartis Institutes for BioMedical Research, Basel, Switzerland.
Janos SteffenDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California, USA.
Mitchel GermainNovartis Institutes for BioMedical Research, Basel, Switzerland.
Laetitia GoepfertNovartis Institutes for BioMedical Research, Basel, Switzerland.
Michael A ContiDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California, USA.
Christoph PottingNovartis Institutes for BioMedical Research, Basel, Switzerland.
Raffaele CerinoNovartis Institutes for BioMedical Research, Basel, Switzerland.
Martin PfeiferNovartis Institutes for BioMedical Research, Basel, Switzerland.
Philipp KrastelNovartis Institutes for BioMedical Research, Basel, Switzerland.
Dominic HoepfnerNovartis Institutes for BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-8450-7543
Julie BastienNovartis Institutes for BioMedical Research, Basel, Switzerland.
Carla M KoehlerDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California, USA.
Stephen B HelliwellNovartis Institutes for BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6019-9574
Novartis (Switzerland) · CHUniversity of California, Los Angeles · US

Funding

Biogenesis of the mitochondrial inner membrane diversity supplementR01GM061721 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOEHLER, CARLA M · 2000 to 2025
$8.1M
NIGMS NIH HHS R01 GM061721
6 · The paper itself

Abstract

Tim17 and Tim23 are the main subunits of the TIM23 complex, one of the two major essential mitochondrial inner-membrane protein translocon machineries (TIMs). No chemical probes that specifically inhibit TIM23-dependent protein import were known to exist. Here we show that the natural product stendomycin, produced by Streptomyces hygroscopicus, is a potent and specific inhibitor of the TIM23 complex in yeast and mammalian cells. Furthermore, stendomycin-mediated blockage of the TIM23 complex does not alter normal processing of the major regulatory mitophagy kinase PINK1, but TIM23 is required to stabilize PINK1 on the outside of mitochondria to initiate mitophagy upon membrane depolarization.

Indexed as

Antimicrobial Cationic PeptidesDose-Response Relationship, DrugHeLa CellsHumansMembrane Transport ProteinsMitochondriaMitochondrial Precursor Protein Import Complex ProteinsMitochondrial ProteinsMolecular StructurePeptidesProtein TransportSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsStructure-Activity RelationshipTumor Cells, CulturedAntimicrobial Cationic PeptidesMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsMitochondrial ProteinsPeptidesSaccharomyces cerevisiae ProteinsstendomycinTIM23 protein, S cerevisiae

Identifiers

PMID28991239
PMCPMC5945950
OpenAlexW2764335444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.